Asset Details
Do you wish to reserve the book?
Exploiting a novel conformational switch to control innate immunity mediated by complement protein C3a
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Exploiting a novel conformational switch to control innate immunity mediated by complement protein C3a
Do you wish to request the book?
Exploiting a novel conformational switch to control innate immunity mediated by complement protein C3a
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Exploiting a novel conformational switch to control innate immunity mediated by complement protein C3a
2017
Overview
Complement C3a is an important protein in innate and adaptive immunity, but its specific roles in vivo remain uncertain because C3a degrades rapidly to form the C3a-desArg protein, which does not bind to the C3a receptor and is indistinguishable from C3a using antibodies. Here we develop the most potent, stable and highly selective small molecule modulators of C3a receptor, using a heterocyclic hinge to switch between agonist and antagonist ligand conformations. This enables characterization of C3 areceptor-selective pro- vs. anti-inflammatory actions in human mast cells and macrophages, and in rats. A C3a receptor-selective agonist induces acute rat paw inflammation by first degranulating mast cells before activating macrophages and neutrophils. An orally administered C3a receptor-selective antagonist inhibits mast cell degranulation, thereby blocking recruitment and activation of macrophages and neutrophils, expression of inflammatory mediators and inflammation in a rat paw edema model. These novel tools reveal the mechanism of C3a-induced inflammation and provide new insights to complement-based medicines.
Complement C3a is an important protein in innate and adaptive immunity, but its roles in vivo are unclear. Here the authors develop novel chemical agonists and antagonists for the C3a receptor, and show that they modulate mast cell degranulation and inflammation in a rat paw edema model
Publisher
Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio
Subject
/ Animals
/ Anti-Asthmatic Agents - pharmacology
/ Cell Degranulation - drug effects
/ Cromolyn Sodium - pharmacology
/ Edema
/ Humanities and Social Sciences
/ Humans
/ Immunity
/ Ligands
/ Male
/ Proteins
/ Rats
/ Receptors, Complement - agonists
/ Receptors, Complement - antagonists & inhibitors
/ Receptors, Complement - chemistry
/ Science
